Management of unilateral idiopathic masseter muscle hypertrophy with botulinum toxin type A
Masseter hypertrophy (MH) is an uncommon disorder which can cause both aesthetic and functional problems. The most common aetiological factors associated with MH are habit of chewing gum, clenching and/or bruxism. The treatment of MH includes conservative management as well as surgical resection of...
Gespeichert in:
| Veröffentlicht in: | BMJ case reports 2021-01, Vol.14 (1), p.e239056 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 1 |
| container_start_page | e239056 |
| container_title | BMJ case reports |
| container_volume | 14 |
| creator | Nilesh, Kumar Dharamsi, Ravina Patil, Pankaj Mate, Payal |
| description | Masseter hypertrophy (MH) is an uncommon disorder which can cause both aesthetic and functional problems. The most common aetiological factors associated with MH are habit of chewing gum, clenching and/or bruxism. The treatment of MH includes conservative management as well as surgical resection of the enlarged muscle and/or bone. Injection of botulinum toxin type A is a relatively new and minimally invasive method for management of masseter muscle hypertrophy, which offers many advantages over conventional surgical management. This paper reports a case of unilateral MH of unknown origin which was treated with injection of botulinum toxin type A, resulting in satisfactory reduction in the volume of muscle and improvement of facial aesthetics. |
| doi_str_mv | 10.1136/bcr-2020-239056 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7813317</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2512723557</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-f99a0cab1109b664aacde48d063467a8981333a621a294cded9aad7d0b34f79d3</originalsourceid><addsrcrecordid>eNpVUU1LxDAQDaKorHv2JgHPdfPRNpuLIOIXrHhREDyEaZtuI21Tk1Tdf2-WXWXNZcLMmzdv5iF0SskFpTyfFaVLGGEkYVySLN9Dx1RkIhGSvO7v_I_Q1Pt3Eh-n6Tzlh-iI8zRnJKXH6O0ReljqTvcB2xqPvWkhaActNpWxA4TGlLgD73XM4m70Zatxsxq0C84OzQp_mdDgwoaxNf3Y4WC_TY9DBOCrE3RQQ-v1dBsn6OX25vn6Plk83T1cXy2SkossJLWUQEooKCWyyPMUoKx0Oq9IHlUKmMs55ZxDzigwmcZaJQEqUZGCp7WQFZ-gyw3vMBadrsq4S1xADc504FbKglH_K71p1NJ-KrFmpiISnG8JnP0YtQ_q3Y6uj5oVyygTjGfZGjXboEpnvXe6_ptAiVoboqIham2I2hgSO852hf3hf8_PfwDw8YmH</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2512723557</pqid></control><display><type>article</type><title>Management of unilateral idiopathic masseter muscle hypertrophy with botulinum toxin type A</title><source>PubMed Central Free</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Nilesh, Kumar ; Dharamsi, Ravina ; Patil, Pankaj ; Mate, Payal</creator><creatorcontrib>Nilesh, Kumar ; Dharamsi, Ravina ; Patil, Pankaj ; Mate, Payal</creatorcontrib><description>Masseter hypertrophy (MH) is an uncommon disorder which can cause both aesthetic and functional problems. The most common aetiological factors associated with MH are habit of chewing gum, clenching and/or bruxism. The treatment of MH includes conservative management as well as surgical resection of the enlarged muscle and/or bone. Injection of botulinum toxin type A is a relatively new and minimally invasive method for management of masseter muscle hypertrophy, which offers many advantages over conventional surgical management. This paper reports a case of unilateral MH of unknown origin which was treated with injection of botulinum toxin type A, resulting in satisfactory reduction in the volume of muscle and improvement of facial aesthetics.</description><identifier>ISSN: 1757-790X</identifier><identifier>EISSN: 1757-790X</identifier><identifier>DOI: 10.1136/bcr-2020-239056</identifier><identifier>PMID: 33462041</identifier><language>eng</language><publisher>England: BMJ Publishing Group LTD</publisher><subject>Botulinum toxin ; Botulinum Toxins, Type A - therapeutic use ; Boundaries ; Case Report ; Case reports ; Female ; Humans ; Hypertrophy - diagnosis ; Infections ; Masseter Muscle - abnormalities ; Masseter Muscle - drug effects ; Neuromuscular Agents - therapeutic use ; Pain ; Teeth ; Tumors ; Young Adult</subject><ispartof>BMJ case reports, 2021-01, Vol.14 (1), p.e239056</ispartof><rights>BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>2021 BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c375t-f99a0cab1109b664aacde48d063467a8981333a621a294cded9aad7d0b34f79d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813317/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813317/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33462041$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nilesh, Kumar</creatorcontrib><creatorcontrib>Dharamsi, Ravina</creatorcontrib><creatorcontrib>Patil, Pankaj</creatorcontrib><creatorcontrib>Mate, Payal</creatorcontrib><title>Management of unilateral idiopathic masseter muscle hypertrophy with botulinum toxin type A</title><title>BMJ case reports</title><addtitle>BMJ Case Rep</addtitle><description>Masseter hypertrophy (MH) is an uncommon disorder which can cause both aesthetic and functional problems. The most common aetiological factors associated with MH are habit of chewing gum, clenching and/or bruxism. The treatment of MH includes conservative management as well as surgical resection of the enlarged muscle and/or bone. Injection of botulinum toxin type A is a relatively new and minimally invasive method for management of masseter muscle hypertrophy, which offers many advantages over conventional surgical management. This paper reports a case of unilateral MH of unknown origin which was treated with injection of botulinum toxin type A, resulting in satisfactory reduction in the volume of muscle and improvement of facial aesthetics.</description><subject>Botulinum toxin</subject><subject>Botulinum Toxins, Type A - therapeutic use</subject><subject>Boundaries</subject><subject>Case Report</subject><subject>Case reports</subject><subject>Female</subject><subject>Humans</subject><subject>Hypertrophy - diagnosis</subject><subject>Infections</subject><subject>Masseter Muscle - abnormalities</subject><subject>Masseter Muscle - drug effects</subject><subject>Neuromuscular Agents - therapeutic use</subject><subject>Pain</subject><subject>Teeth</subject><subject>Tumors</subject><subject>Young Adult</subject><issn>1757-790X</issn><issn>1757-790X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpVUU1LxDAQDaKorHv2JgHPdfPRNpuLIOIXrHhREDyEaZtuI21Tk1Tdf2-WXWXNZcLMmzdv5iF0SskFpTyfFaVLGGEkYVySLN9Dx1RkIhGSvO7v_I_Q1Pt3Eh-n6Tzlh-iI8zRnJKXH6O0ReljqTvcB2xqPvWkhaActNpWxA4TGlLgD73XM4m70Zatxsxq0C84OzQp_mdDgwoaxNf3Y4WC_TY9DBOCrE3RQQ-v1dBsn6OX25vn6Plk83T1cXy2SkossJLWUQEooKCWyyPMUoKx0Oq9IHlUKmMs55ZxDzigwmcZaJQEqUZGCp7WQFZ-gyw3vMBadrsq4S1xADc504FbKglH_K71p1NJ-KrFmpiISnG8JnP0YtQ_q3Y6uj5oVyygTjGfZGjXboEpnvXe6_ptAiVoboqIham2I2hgSO852hf3hf8_PfwDw8YmH</recordid><startdate>20210118</startdate><enddate>20210118</enddate><creator>Nilesh, Kumar</creator><creator>Dharamsi, Ravina</creator><creator>Patil, Pankaj</creator><creator>Mate, Payal</creator><general>BMJ Publishing Group LTD</general><general>BMJ Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20210118</creationdate><title>Management of unilateral idiopathic masseter muscle hypertrophy with botulinum toxin type A</title><author>Nilesh, Kumar ; Dharamsi, Ravina ; Patil, Pankaj ; Mate, Payal</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-f99a0cab1109b664aacde48d063467a8981333a621a294cded9aad7d0b34f79d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Botulinum toxin</topic><topic>Botulinum Toxins, Type A - therapeutic use</topic><topic>Boundaries</topic><topic>Case Report</topic><topic>Case reports</topic><topic>Female</topic><topic>Humans</topic><topic>Hypertrophy - diagnosis</topic><topic>Infections</topic><topic>Masseter Muscle - abnormalities</topic><topic>Masseter Muscle - drug effects</topic><topic>Neuromuscular Agents - therapeutic use</topic><topic>Pain</topic><topic>Teeth</topic><topic>Tumors</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nilesh, Kumar</creatorcontrib><creatorcontrib>Dharamsi, Ravina</creatorcontrib><creatorcontrib>Patil, Pankaj</creatorcontrib><creatorcontrib>Mate, Payal</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMJ case reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nilesh, Kumar</au><au>Dharamsi, Ravina</au><au>Patil, Pankaj</au><au>Mate, Payal</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Management of unilateral idiopathic masseter muscle hypertrophy with botulinum toxin type A</atitle><jtitle>BMJ case reports</jtitle><addtitle>BMJ Case Rep</addtitle><date>2021-01-18</date><risdate>2021</risdate><volume>14</volume><issue>1</issue><spage>e239056</spage><pages>e239056-</pages><issn>1757-790X</issn><eissn>1757-790X</eissn><abstract>Masseter hypertrophy (MH) is an uncommon disorder which can cause both aesthetic and functional problems. The most common aetiological factors associated with MH are habit of chewing gum, clenching and/or bruxism. The treatment of MH includes conservative management as well as surgical resection of the enlarged muscle and/or bone. Injection of botulinum toxin type A is a relatively new and minimally invasive method for management of masseter muscle hypertrophy, which offers many advantages over conventional surgical management. This paper reports a case of unilateral MH of unknown origin which was treated with injection of botulinum toxin type A, resulting in satisfactory reduction in the volume of muscle and improvement of facial aesthetics.</abstract><cop>England</cop><pub>BMJ Publishing Group LTD</pub><pmid>33462041</pmid><doi>10.1136/bcr-2020-239056</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1757-790X |
| ispartof | BMJ case reports, 2021-01, Vol.14 (1), p.e239056 |
| issn | 1757-790X 1757-790X |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7813317 |
| source | PubMed Central Free; MEDLINE; EZB-FREE-00999 freely available EZB journals |
| subjects | Botulinum toxin Botulinum Toxins, Type A - therapeutic use Boundaries Case Report Case reports Female Humans Hypertrophy - diagnosis Infections Masseter Muscle - abnormalities Masseter Muscle - drug effects Neuromuscular Agents - therapeutic use Pain Teeth Tumors Young Adult |
| title | Management of unilateral idiopathic masseter muscle hypertrophy with botulinum toxin type A |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T07%3A06%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Management%20of%20unilateral%20idiopathic%20masseter%20muscle%20hypertrophy%20with%20botulinum%20toxin%20type%20A&rft.jtitle=BMJ%20case%20reports&rft.au=Nilesh,%20Kumar&rft.date=2021-01-18&rft.volume=14&rft.issue=1&rft.spage=e239056&rft.pages=e239056-&rft.issn=1757-790X&rft.eissn=1757-790X&rft_id=info:doi/10.1136/bcr-2020-239056&rft_dat=%3Cproquest_pubme%3E2512723557%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2512723557&rft_id=info:pmid/33462041&rfr_iscdi=true |